It was also found that contemporary adverse pathological features, such as cribriform Gleason pattern 4 carcinoma and intraductal carcinoma, are associated with underlying molecular alterations, including MYC and PTEN genomic status, providing additional support for their use in pathologic evaluation. The gene discussed is MYC; the disease is ductal breast carcinoma in situ.